Related references
Note: Only part of the references are listed.Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer
Si-Si Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations
Xin Sun et al.
LIFE SCIENCES (2021)
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling
Bas Ponsioen et al.
NATURE CELL BIOLOGY (2021)
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
S. S. Ramalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations
Riyaz Shah et al.
CLINICAL LUNG CANCER (2020)
The Biogenesis and Precise Control of RNA m6A Methylation
Huilin Huang et al.
TRENDS IN GENETICS (2020)
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang et al.
CANCER CELL (2020)
Hormonal Suppression of Stem Cells Inhibits Symmetric Cell Division and Gastric Tumorigenesis
Wenju Chang et al.
CELL STEM CELL (2020)
m6A Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells
Gege Yan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Methyltransferase-like 3-mediated N6-methyladenosine modification of miR-7212-5p drives osteoblast differentiation and fracture healing
Bobin Mi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Methyltransferase 3 Mediated miRNA m6A Methylation Promotes Stress Granule Formation in the Early Stage of Acute Ischemic Stroke
Wenwen Si et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs
Lele Zhang et al.
MOLECULAR CANCER (2020)
TISIDB: an integrated repository portal for tumor-immune system interactions
Beibei Ru et al.
BIOINFORMATICS (2019)
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Ayesha Murtuza et al.
CANCER RESEARCH (2019)
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
J. Gao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
The role of m6A RNA methylation in human cancer
Xiao-Yu Chen et al.
MOLECULAR CANCER (2019)
Tobacco and the lung cancer epidemic in China
Mark Parascandola et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
The interplay between m6A RNA methylation and noncoding RNA in cancer
Shuai Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
Maosheng Cheng et al.
ONCOGENE (2019)
The emerging role of mRNA methylation in normal and pathological behavior
M. Engel et al.
GENES BRAIN AND BEHAVIOR (2018)
Acquired resistance in oncogene-addicted non-small-cell lung cancer
Claudio Sini et al.
FUTURE ONCOLOGY (2018)
CCAT1 stimulation of the symmetric division of NSCLC stem cells through activation of the Wnt signalling cascade
C. Xu et al.
GENE THERAPY (2018)
METTL3-mediated m6 A modification is required for cerebellar development
Chen-Xin Wang et al.
PLOS BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anti-cancer Effects of Polyphenolic Compounds in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
Hyungmin Jeong et al.
PHARMACOGNOSY MAGAZINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells
Guodong Xiao et al.
CELL CYCLE (2017)
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
Dana S. Neel et al.
NPJ PRECISION ONCOLOGY (2017)
Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells
X. Sun et al.
CANCER GENE THERAPY (2016)
The insights of Let-7 miRNAs in oncogenesis and stem cell potency
Xin Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
Jessica J. Lin et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Cancer prevention and control: alarming challenges in China
Ann M. Bode et al.
NATIONAL SCIENCE REVIEW (2016)
Resisting Resistance: Targeted Therapies in Lung Cancer
Jessica J. Lin et al.
TRENDS IN CANCER (2016)
Prevention and management of lung cancer in China
Qun-Ying Hong et al.
CANCER (2015)
DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1
Xin Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
The Wnt-β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion
Wang-Yu Cai et al.
JOURNAL OF CELL SCIENCE (2013)
Share Paper
